Pearl River Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,445
Closed -$1.14M 535
2023
Q4
$1.14M Sell
15,445
-20,355
-57% -$1.33M 0.18% 177
2023
Q3
$2.44M Sell
35,800
-182
-0.5% -$15.4K 0.38% 75
2023
Q2
$3.38M Buy
35,982
+5,505
+18% +$429K 0.54% 38
2023
Q1
$2.07M Sell
30,477
-8,232
-21% -$529K 0.33% 93
2022
Q4
$1.92M Buy
38,709
+24,543
+173% +$1M 0.33% 96
2022
Q3
$460K Buy
+14,166
New +$584K 0.09% 299
2021
Q2
Sell
-4,709
Closed -$621K 460
2021
Q1
$621K Buy
+4,709
New +$645K 0.2% 160
2020
Q4
Sell
-2,974
Closed -$303K 417
2020
Q3
$303K Buy
+2,974
New +$257K 0.13% 251
2020
Q2
Sell
-2,563
Closed -$149K 386
2020
Q1
$149K Buy
+2,563
New +$208K 0.29% 121
2019
Q2
Sell
-800
Closed -$70K 345
2019
Q1
$70K Buy
+800
New +$68.1K 0.17% 210

Other funds holding EXAS

Pearl River Capital's EXAS Position: Q1 2024 in Review

Pearl River Capital sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 15,445 shares — an estimated $1.14M sold.

Pearl River Capital first reported a position in EXAS in Q1 2019 and held it in 10 quarters. The position peaked at $3.38M in Q2 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Pearl River Capital reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Pearl River Capital sold 15,445 Exact Sciences shares in Q1 2024, an estimated $1.14M.
  • Pearl River Capital first reported a position in Exact Sciences in Q1 2019 and held it in 10 quarters.
  • Pearl River Capital's Exact Sciences position peaked at $3.38M in Q2 2023.
  • 626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Pearl River Capital's 13F filing for Q1 2024, filed 14 May 2024.